Search Results - "Fumitoshi HIRAYAMAb"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Stabilizing Effect of β-Cyclodextrin on Limaprost, a PGE1 Derivative, in Limaprost Alfadex Tablets (Opalmon(R)) in Highly Humid Conditions by Yasuo Inouea, Noboru Sekiyaa, Kazunori Katayamaa, Shoji Narutakia, Masanobu Yamamotoa, Daisuke Ioharab, Fumitoshi Hirayamab, Kaneto Uekamac

    Published in Chemical and Pharmaceutical Bulletin (01-08-2014)
    “…Stabilization against humidity of Limaprost (a prostaglandin E1 derivative), which is currently marketed as Opalmon(R), was undertaken using β-cyclodextrin…”
    Get full text
    Journal Article
  2. 2

    Involvement of Lipid Rafts of Rabbit Red Blood Cells in Morphological Changes Induced by Methylated β-Cyclodextrins by Keiichi MOTOYAMAa, Hiroshi TOYODOMEa, Risako ONODERAa, Tetsumi IRIEa, Fumitoshi HIRAYAMAb, Kaneto UEKAMAb, Hidetoshi ARIMAa

    Published in Biological & Pharmaceutical Bulletin (01-04-2009)
    “…Lipid rafts on cell membranes have heterogeneity such as cholesterol-rich microdomains and sphingolipidsrich microdomains. We previously reported…”
    Get full text
    Journal Article
  3. 3

    Potential Use of 2-Hydroxypropyl-β-cyclodextrin for Preparation of Orally Disintegrating Tablets Containing dl-α-Tocopheryl Acetate, an Oily Drug by Keiichi MOTOYAMAa, Kiyoshi NAGATOMOa, Soliman Osama Abd ELAZIMa, Fumitoshi HIRAYAMAb, Kaneto UEKAMAb, Hidetoshi ARIMAa

    Published in Chemical & Pharmaceutical Bulletin (01-11-2009)
    “…To expand the application of a drug in orally disintegrating tablets, the potential use of β-cyclodextrin (β-CyD) and 2-hydroxypropyl-β-cyclodextrin (HP-β-CyD)…”
    Get full text
    Journal Article
  4. 4

    Preparation of Four Types of Coenzyme Q10/γ-Cyclodextrin Supramolecular Complexes and Comparison of Their Pharmaceutical Properties by Taishi HIGASHIa, Katsunori NISHIMURAa, Ayumi YOSHIMATSUa, Haruna IKEDAa, Kanako ARIMAa, Keiichi MOTOYAMAa, Fumitoshi HIRAYAMAb, Kaneto UEKAMAb, Hidetoshi ARIMAa

    Published in Chemical & Pharmaceutical Bulletin (01-09-2009)
    “…In this study, we prepared four kinds of complexes of Coenzyme Q10 (CoQ10) with γ-cyclodextrin (γ-CyD) by the kneading methods and the solubility methods with…”
    Get full text
    Journal Article
  5. 5

    Pseudorotaxane-Like Supramolecular Complex of Coenzyme Q10 with γ-Cyclodextrin Formed by Solubility Method by Katsunori NISHIMURAa, Taishi HIGASHIa, Ayumi YOSHIMATSUa, Fumitoshi HIRAYAMAb, Kaneto UEKAMAb, Hidetoshi ARIMAa

    Published in Chemical & Pharmaceutical Bulletin (01-05-2008)
    “…The purpose of this study is to reveal whether Coenzyme Q1O (CoQ10) forms pseudorotaxane-like supramolecular complex withγ-cyclodextrin (γ-CyD). The poorly…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Synthesis, Aggregation Behavior, and Photodynamic Properties of a Water-Soluble Fulleropyrrolidine Bearing an N-PEG Pyridinium Unit by Mizuki, Keiji, Matsumoto, Seigo, Honda, Taro, Maeda, Kouhei, Toyama, Satoshi, Iohara, Daisuke, Hirayama, Fumitoshi, Okazaki, Shoko, Takeshita, Keizo, Hatta, Taizo

    Published in Chemical & pharmaceutical bulletin (01-08-2018)
    “…Herein, we describe the synthesis of a water-soluble photodynamically active fullerene bearing a polyethylene glycol chain and a hydrophilic cationic group,…”
    Get full text
    Journal Article
  8. 8

    A Comparison of the Phosphorus Content in Prescription Medications for Hemodialysis Patients in Japan by Shimoishi, Kazuki, Anraku, Makoto, Uto, Ayako, Iohara, Daisuke, Hirayama, Fumitoshi, Kadowaki, Daisuke, Zingami, Sachiko, Maruyama, Toru, Otagiri, Masaki

    Published in YAKUGAKU ZASSHI (01-07-2017)
    “…A high dietary intake of phosphorus is considered to be a significant health threat for hemodialysis (HD) patients. Prescription medications, which might be a…”
    Get full text
    Journal Article
  9. 9